Introducing DosoLogic.
Precision Pharmacology Software Improving Benefit vs. Risk
when Dosing Critical Therapies
Interpretable Dosing Insights
Empowering decision-makers with best-practice pharmacology modelling via a user-friendly clinical interface. This offers actionable recommendations in areas including oncology, anti-infectives, rheumatology and immunology.
Seamless Accessiblity
User-led development and integration with prominent electronic health record systems ensures minimal impact to clinical workflows and widespread availability at the point-of-care.
Maximised Therapeutic Potential
Dose individualization increases the likelihood of achieving target therapeutic effect and minimising drug-related adverse events for each patient. This reduces time in hospital and improves quality of life.
How it Works
01.
Data: patient, sample, regimen info, drug & marker levels collected via EHR integration
02.
Modelling: data used to generate drug-specific pharmacology model for patient population
03.
Simulation: model is applied to treatment scenario(s) considering historic patient response
04.
Recommendation:
multiple dosing options offered alongside predicted outcome
05.
Optimisation: real-world data, continuously improves model predictive performance
Our Health is Personal.
Why Isn't Our Treatment?
One Size Fits All Dosing
Drug dose selection is guided by patient body weight or surface area. This approach does not fully consider differences between how patient groups process their medication.
Variability in Drug Exposure
Adoption of broad dosing labels can cause unpredictable drug-levels between individuals and patient groups, limiting therapeutic benefit or increasing the likelihood of toxicity.
Quality of Life Impact
Sub-optimal drug exposures causes inequitable outcomes, with 1-in-4 cancer survivors suffering from disease related side effects, costing care providers >$500bn per year.
Backed by
Hear from future adopters
Pamela Kearns
Professor of Clinical Paediatric Oncology,
University of Birmingham
“DosoLogic will allow us to individualise the dose of chemotherapy
to maximise effect on the tumour while
minimising the short and long term side effects.”
